全文获取类型
收费全文 | 3404篇 |
免费 | 182篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 69篇 |
妇产科学 | 75篇 |
基础医学 | 376篇 |
口腔科学 | 122篇 |
临床医学 | 231篇 |
内科学 | 688篇 |
皮肤病学 | 115篇 |
神经病学 | 89篇 |
特种医学 | 171篇 |
外国民族医学 | 4篇 |
外科学 | 701篇 |
综合类 | 86篇 |
一般理论 | 2篇 |
预防医学 | 273篇 |
眼科学 | 77篇 |
药学 | 285篇 |
中国医学 | 14篇 |
肿瘤学 | 200篇 |
出版年
2024年 | 3篇 |
2023年 | 35篇 |
2022年 | 127篇 |
2021年 | 205篇 |
2020年 | 101篇 |
2019年 | 131篇 |
2018年 | 144篇 |
2017年 | 90篇 |
2016年 | 111篇 |
2015年 | 131篇 |
2014年 | 169篇 |
2013年 | 195篇 |
2012年 | 255篇 |
2011年 | 311篇 |
2010年 | 187篇 |
2009年 | 154篇 |
2008年 | 208篇 |
2007年 | 210篇 |
2006年 | 181篇 |
2005年 | 144篇 |
2004年 | 121篇 |
2003年 | 136篇 |
2002年 | 101篇 |
2001年 | 21篇 |
2000年 | 23篇 |
1999年 | 21篇 |
1998年 | 9篇 |
1997年 | 5篇 |
1996年 | 12篇 |
1995年 | 5篇 |
1994年 | 3篇 |
1993年 | 2篇 |
1992年 | 4篇 |
1991年 | 4篇 |
1990年 | 4篇 |
1989年 | 2篇 |
1988年 | 5篇 |
1987年 | 3篇 |
1986年 | 2篇 |
1984年 | 4篇 |
1976年 | 7篇 |
1974年 | 1篇 |
1973年 | 3篇 |
1972年 | 3篇 |
1969年 | 3篇 |
1967年 | 1篇 |
1966年 | 1篇 |
1924年 | 1篇 |
1923年 | 1篇 |
1921年 | 1篇 |
排序方式: 共有3606条查询结果,搜索用时 2 毫秒
31.
Khaled Al-Noury 《Indian journal of otolaryngology and head and neck surgery》2012,64(2):162-166
Classically, teaching of otological micro procedures is achieved by cadaveric dissection of the temporal bones, achieved by attending expensive temporal bone dissection courses. The difficulty in acquiring cadaveric specimens and the cost of courses has led to the development of alternative techniques. The aim of this study is to evaluate the efficacy of using virtual reality temporal bone simulation in training otolaryngology residents for mastoidectomy procedures. Four senior residents were evaluated during six canal wall down mastoidectomy procedures. Three of these procedures were done conventionally. The other three procedures were preceded by virtual reality simulation 1 day before the operation. In simulated cases, the residents scored higher on the global rating scale and task-based checklist, and were faster and more confident. Further, fewer instructions were required during the actual operation. This outcome is encouraging for the utilization of virtual reality simulation in otolaryngology residency training. Further studies should be performed on a larger number of simulators and surgical procedures to validate our results. 相似文献
32.
Khaled Sirajedine Rida Fardous Mohamad Al Adib Henry Colomb Audrey Maurin 《Néphrologie & thérapeutique》2012,8(4):226-230
IntroductionGeriatric Nutritional Risk Index (GNRI) is a simple and quantitative method (based on three objective measurements: weight, height, albumin) for screening patients at risk for malnutrition. However no data are available regarding its relation with mortality in Caucasian hemodialysis patients. We tested the predictive value of GNRI on mortality in a hemodialysis population followed up prospectively for 18 months.MethodsA total of 46 stable prevalent (mean age: 76 ± 11 years, range: 42–95) hemodialysis patients from one center were included in the study. GNRI with other nutritional parameters were evaluated for all patients.ResultsSixteen patients (35%) died during the 18 months of follow-up. Multiple logistic model showed that GNRI and Charlson co-morbidity score were significant predictors of mortality. Age and gender were not significant.ConclusionOur preliminary study carried out on a series of prevalent hemodialysis patients suggests that GNRI is predictor of mortality. To recommend the use of this index for the screening of hemodialysis patients with malnutrition at risk of mortality, our results should be confirmed by a large cohort study. 相似文献
33.
Stefanie Gierer Heike Hofmann-Winkler Waleed H. Albuali Stephanie Bertram Abdullah M. Al-Rubaish Abdullah A. Yousef Awatif N. Al-Nafaie Amein K. Al-Ali Obeid E. Obeid Khaled R. Alkharsah Stefan P?hlmann 《Emerging infectious diseases》2013,19(12):2034-2036
We used a lentiviral vector bearing the viral spike protein to detect neutralizing antibodies against Middle East respiratory syndrome coronavirus (MERS-CoV) in persons from the Eastern Province of Saudi Arabia. None of the 268 samples tested displayed neutralizing activity, which suggests that MERS-CoV infections in humans are infrequent in this province. 相似文献
34.
35.
Gelan M. Salem Wafik M. El-Sheik Basma G. El-shanawany Khaled H. Afifi 《Neurosciences (Riyadh, Saudi Arabia)》2021,26(2):179
Objectives:To assess low dose altepase outcome and safety in comparison with a standard-dose regimen for acute ischemic stroke treatment in Egyptian patients.Materials:An observational prospective cohort non-randomized single blinded study was carried out during the period from November 2017 to December 2018. Eighty Egyptian acute ischemic stroke patients, all eligible for intravenous alteplase, were subdivided into 2 groups (40 patients in each group). Patients were thrombolysed at a dose of 0.6 mg/kg in the first group and 0.9 mg/kg in the second group. Both groups were compared in regard to safety and outcome. Safety was expressed by the rate of symptomatic intracranial hemorrhage (SICH) and 3 months mortality, while outcome was expressed by favorable outcomes at three months (modified Rankin Scale [mRS] of 0 to 2).Results:In the first group, 69.2% (n=27) achieved favorable outcomes at 90 days compared with 64.1% (n=25) in the second group (p=0.631). Ninety-day mortality was 5% (n=2) in the first group versus 2.5% (n=1) in the second group (p=0.556). Symptomatic intracranial hemorrhage was noted in 3 patients in the second group and zero patients in the first group (p=0.077).Conclusion:Low-dose alteplase could be a practical alternative for Egyptian populations with acute ischemic stroke especially in 3 to 4.5 hours window.Cerebrovascular stroke is the second death and the seventh disability leading cause worldwide.1 Tissue-type plasminogen activator (tPA) alteplase was the first medication approved by the Food and Drug Administration (FDA) for the acute ischemic stroke (AIS) treatment on June 1996, within 3 hours of stroke onset with a recommended dose of 0.9 mg/kg (maximum 90mg).2 In 2008, the safety of using alteplase within 3 to 4.5 hours of stroke onset was approved by the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Registry (SITS -ISTR)3 and the European Cooperative Acute Stroke Study (ECASS III).4 However, thrombolytic therapy use has not been widely adopted, especially in developing countries. The restricted time window (3 to 4.5 hours), intracerebral hemorrhage (ICH) risk and the drug high cost are major obstacles preventing its broad application.5 Coagulation and fibrinolysis responses differ among different races, which increase symptomatic intracerebral hemorrhage (SICH) risk with standard-dose alteplase6 in Asian populations, many Asian neurologists considered alteplase low dose to be a better alternative for ischemic stroke treatment. Many studies had been conducted in order to prove the efficacy and safety of Alteplase low dose.7-9 One of these studies was the Japan Alteplase Clinical Trial (J-ACT) conducted by Yamaguchi et al10 According to this study, using a 0.6 mg/kg dose of intravenous recombinant tissue plasminogen activator (rtPA) in Japanese patients was safe and effective. Despite the relatively stroke high rate among Egyptian populations, 963/100,000 inhabitants, only less than 1% of stroke patients receive intravenous thrombolysis. A major reason for this is the drug cost.11,12 Low-dose regimens (0.6 mg/kg) use will lower the economic burden of thrombolytic therapy in the community and will greatly promote the implementation of this therapy in Egypt. Our study aim was to assess the outcome and safety of alteplase low dose in comparison to the standard-dose regimen in AIS treatment in Egypt. 相似文献
36.
Patient safety is a fundamental aspect of a healthcare system. The aim of this study was to assess the perception and determinants of the patient safety culture of pharmacists in hospitals, in Riyadh, Saudi Arabia.A survey was conducted with pharmacists in the pharmacies of governmental, /military and private hospitals in Riyadh, Saudi Arabia. The pharmacy survey on patient safety culture questionnaire developed by Agency for Healthcare Research and Qualtity, a hard copy was distriuted to the pharmacists. The positive response rate (RR) was calculated and compared across hospitals using a chi-square test. The predictors of patient safety grades were identified using the generalized estimating equation. The data was analyzed using SAS.A total of 538 questionnaires were distributed, of which 411 responded (RR 76.4%). Of the participants, 229 (56%) were females. The majority 255 (62%) were in the 18 to 34 years age range, and 361 (88%) had a bachelor''s degree. The majority of the sample 376 (92%) was a pharmacist. The Positive RR (PRR) ranged between (25.6%–74%). The highest PRR was observed in teamwork (74.4%), followed by ‘staff, training and skills’ (68%), and ‘organizational learning continuous improvement’ (66%). The lowest PRR was observed in ‘staffing, work pressure, and pace’ (25.5%). Comparing the PPR of the various healthcare sectors, the governmental hospitals scored the highest in all patient safety domains. Generalized Estimating Equation analysis showed that with increase in scores of all patient safety culture domains increased the likelihood of reporting a better patient safety grade, whereas respondents’ demographic characteristics had no effect except the working experience years 6 years and above had odds of poor reporting of the patient safety grade (odds ratio = 2.54, 95% confience interval (1.543, 4.194), (P = .0003).The grades achieved in the various domains of patient safety culture by pharmacists in Riyadh are below the expected standard. The highest scores were achieved in teamwork, with the lowest scores in staffing, work pressure and pace. Overall, pharmacists in government hospital settings have a better perception of patient safety than their peers in other settings. These results provide the baseline evidence for developing future interventional studies aiming at improving patient safety culture in hospital pharmacy settings. 相似文献
37.
N Alrashdi Mousa Saleh Alanazi Majed Khalid Almoaqly Alshaya Abdulrahman Khaled Alanazi Sultan Mahja Marzouq 《Clinical rheumatology》2022,41(5):1577-1582
Clinical Rheumatology - Coronavirus disease-19 (COVID-19) is a global pandemic that is caused by COVID-19 virus, which was initially identified in December 2019 in Wuhan, China. Vaccination is one... 相似文献
38.
Effect of different fixative solutions on eyes with experimental proliferative vitreoretinopathy 下载免费PDF全文
Khaled Nassar Julia Lüke Matthias Lüke Mahmoud Kamal Mahmoud M Soliman Salvatore Grisanti Swaantje Grisanti 《International journal of experimental pathology》2015,96(2):103-110
The aim of this study was to evaluate the use of different fixatives on the reliability of histopathological changes in a rabbit model of proliferative vitreoretinopathy (PVR). Twenty eyes from 10 rabbits were divided into four groups. The right eyes were used in two experimental groups (each n = 5), and the left, in two control groups (each n = 5). Using a newly developed scleral incision marker, an oblique scleral incision was standardized in the experimental groups, followed by intravitreal injection of 0.4 ml autologous blood and the left for wound repair for four weeks. Eyes were enucleated at four weeks. The groups differed in the type of used fixative solution (formaldehyde 4% vs. 1% buffered formaldehyde and 1.25% glutaraldehyde). The eyes were evaluated for the development of fibrosis, retinal detachment (RD), and processed for histopathology. Fibrous ingrowth of a variable degree was present in the experimental groups originating from the trauma site. Experimental eyes fixed with formaldehyde 4% had RD extension that was greater than that fixed in formaldehyde/glutaraldehyde mixture; however, the difference did not reach statistical significance (P = 0.15). This difference was not fully explained by the fibrosis which developed. In addition, in control groups, formaldehyde 4% induced a fixative-dependent retinal separation that was absent in eyes fixed with formaldehyde/glutaraldehyde mixture (P = 0.03). In conclusion, a mixture of buffered formaldehyde 1% and glutaraldehyde 1.25% combined with standardized scleral incision resulted in consistent pathological changes. A reliable PVR model is a condition sine qua non to evaluate antifibrotic treatment strategies. 相似文献
39.
40.
Al-Herz Adeeba Saleh Khuloud Al-Awadhi Adel Al-Kandari Waleed Hasan Eman Ghanem Aqeel Hussain Mohammed Ali Yaser Nahar Ebrahim Alenizi Ahmad Hayat Sawsan Abutiban Fatemah Aldei Ali Alhajeri Hebah Alhadhood Naser Bahbahani Husain Tarakmeh Hoda Mokaddem Khaled Khadrawy Ahmad Fazal Ammad Zaman Agaz Mazloum Ghada Bartella Youssef Hamed Sally Alsouk Ramia Al-Saber Ahmed 《Clinical rheumatology》2021,40(5):1759-1765
Clinical Rheumatology - Biologics are indicated in rheumatoid arthritis (RA) in case of persistent high disease activity despite conventional disease-modifying anti-rheumatic drugs (cDMARDs) or... 相似文献